Combat Drugs standalone net profit rises 200.00% in the March 2018 quarter

Sales rise 255.56% to Rs 0.32 crore

Net profit of Combat Drugs rose 200.00% to Rs 0.03 crore in the quarter ended March 2018 as against Rs 0.01 crore during the previous quarter ended March 2017. Sales rose 255.56% to Rs 0.32 crore in the quarter ended March 2018 as against Rs 0.09 crore during the previous quarter ended March 2017.

For the full year,net profit reported to Rs 0.18 crore in the year ended March 2018 as against net loss of Rs 0.18 crore during the previous year ended March 2017. Sales rose 31.58% to Rs 0.50 crore in the year ended March 2018 as against Rs 0.38 crore during the previous year ended March 2017.

ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales0.320.09 256 0.500.38 32 OPM %-28.1311.11 --90.00-47.37 - PBDT0.030.01 200 0.18-0.18 LP PBT0.030.01 200 0.18-0.18 LP NP0.030.01 200 0.18-0.18 LP

Powered by Capital Market - Live News